Village malaria workers and lab technicians who will carry out the biosensor G6PD testing among the healthy individuals Febrile patients and vivax malaria patients in two locations of Cambodia. G6PD Point-of-care quantitative test vivax malaria village malaria workers health workers radical cure regimen operational evidence
Conditions
Interventions
Village malaria workers and lab technicians
,Vivax malaria patients at the community who will be seen and tested by VMW and will be referred to health center for re-
testing and appropriate treatment.,Febrile patients at the community
Other,Other,Other
Healthy volunteers ,Vivax malaria patients ,Febrile patients at the community
Sponsors
Joint Global Health Trials MRC
Wellcome Trust
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: 1.Participant is willing and able to give informed consent for participation in the study. 2.Male or female, aged 18 years or above. 3.Healthy volunteers (VMWs or lab technicians), febrile patients or vivax malaria patients who are willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1.Healthy participants (VMWs or lab technicians) or febrile patients or vivax malaria patients who are suffering from severe disease or condition such that testing on them may add burden to them. 2.Patients who are not willing to travel to/follow up at the local health centre for radical cure treatment. 3.Patients or healthy participants who fear blood or needles.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the biosensor use and its outcome between village malaria workers and the lab technicians Day0, during the initial orientation day about the biosensor Correct or incorrect procedure/use of biosensor,Compare the biosensor use and its outcome between village malaria workers and the lab technicians Day0, during the initial orientation day about the biosensor Correct or incorrect interpretation, procedure of biosensor, technical problems,To compare the biosensor use and its outcome between village malaria workers and the lab technicians Day0, during the initial orientation day about the biosensor Interpretations of errors/technical problems | — |
Secondary
| Measure | Time frame |
|---|---|
| Explore the other clinical characteristics of vivax malaria patients Day 30, Day330-365 Clinical characteristics of patients.,Explore the prevalence of G6PD deficiency, Hb levels of vivax malaria patients Day 30, Day330-365 Prevalence of G6PD deficiency and Hb levels,Assess the feasibility and ease of use of biosensors at the field and lab-facility level. Day 30, Day330-365 Percentage of VMW who use the biosensor correctly and Perceived convenience of use, interpretations. | — |
Countries
Cambodia
Contacts
Public ContactLorenz Seidlein
Mahidol-Oxford Tropical Medicine Research Unit (MORU)
Outcome results
None listed